Cargando…
Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia
BACKGROUND: Hypoglycemia is the main side effect of intensified insulin therapy in type 1 diabetes and recognized as a limitation in achieving glycemic targets. Patients with impaired awareness of hypoglycemia have a threefold to sixfold increased risk of severe hypoglycemia. Real-time continuous gl...
Autores principales: | van Beers, Cornelis A.J., Kleijer, Susanne J., Serné, Erik H., Geelhoed-Duijvestijn, Petronella H., Snoek, Frank J., Kramer, Mark H.H., Diamant, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546209/ https://www.ncbi.nlm.nih.gov/pubmed/26292721 http://dx.doi.org/10.1186/s12902-015-0040-3 |
Ejemplares similares
-
DPARD: rationale, design and initial results from the Dutch national diabetes registry
por: Bak, Jessica C. G., et al.
Publicado: (2021) -
Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes
por: Wellens, Martine J, et al.
Publicado: (2021) -
A cost of illness study of hypoglycaemic events in insulin-treated diabetes in the Netherlands
por: de Groot, Saskia, et al.
Publicado: (2018) -
Type 2 diabetes in South Asians compared to Europeans: Higher risk and earlier development of major cardiovascular events irrespective of the presence and degree of retinopathy. Results from The HinDu The Hague Diabetes Study
por: van Niel, Judith, et al.
Publicado: (2021) -
Differentiating Hypoglycemia Awareness Status from Hypoglycemia Experience in Tools for Measuring Impaired Awareness of Hypoglycemia
por: Sepúlveda, Eduardo, et al.
Publicado: (2020)